APA

Hara H., Hara H., Hironaka T., Inoue M., Iida A., Shu T., Hasegawa M., Nagai Y., Falsey A. R., Kamali A., Anzala O., Sanders E. J., Karita E., Mwananyanda L., Vasan S., Lombardo A., Parks C. L., Sayeed E., Krebs M., Cormier E., Ackland J., Price M. A. & Excler J. (20111220). Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors. : Human vaccines.

Chicago

Hara Hiroto, Hara Hiroto, Hironaka Takashi, Inoue Makoto, Iida Akihiro, Shu Tsugumine, Hasegawa Mamoru, Nagai Yoshiyuki, Falsey Ann R, Kamali Anatoli, Anzala Omu, Sanders Eduard J, Karita Etienne, Mwananyanda Lawrence, Vasan Sandhya, Lombardo Angela, Parks Christopher L, Sayeed Eddy, Krebs Marietta, Cormier Emmanuel, Ackland James, Price Matthew A and Excler Jean-Louis. 20111220. Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors. : Human vaccines.

Harvard

Hara H., Hara H., Hironaka T., Inoue M., Iida A., Shu T., Hasegawa M., Nagai Y., Falsey A. R., Kamali A., Anzala O., Sanders E. J., Karita E., Mwananyanda L., Vasan S., Lombardo A., Parks C. L., Sayeed E., Krebs M., Cormier E., Ackland J., Price M. A. and Excler J. (20111220). Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors. : Human vaccines.

MLA

Hara Hiroto, Hara Hiroto, Hironaka Takashi, Inoue Makoto, Iida Akihiro, Shu Tsugumine, Hasegawa Mamoru, Nagai Yoshiyuki, Falsey Ann R, Kamali Anatoli, Anzala Omu, Sanders Eduard J, Karita Etienne, Mwananyanda Lawrence, Vasan Sandhya, Lombardo Angela, Parks Christopher L, Sayeed Eddy, Krebs Marietta, Cormier Emmanuel, Ackland James, Price Matthew A and Excler Jean-Louis. Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors. : Human vaccines. 20111220.